Processa Pharmaceuticals Inc — Financial Statements (NASDAQ:PCSA)

Financials

Total revenue 000—— — Gross profit 000—— — Operating expenses 4.06 M5.48 M16.85 M5.66 M4.78 M 5.61 M Selling/general/admin expenses 3.26 M4.69 M8.76 M5.66 M4.78 M 5.61 M Research & development 3.17 M6.88 M11.49 M5.8 M7.27 M 7.41 M Operating income 15.14 M-12.13 M-27.53 M-11.46 M-12.05 M -13.02 M Non-Operating Income, Total 3 17411.99 K101.2 K335.54 K201.09 K — Interest expense, net of interest capitalized 281.12 K362——— — Non-Operating Income, excl. Interest Expenses -277.95 K11.63 K101.2 K335.54 K201.09 K — Unusual income/expense ————— — Pretax income 15.41 M-11.96 M-27.42 M-11.12 M-11.85 M -12.94 M Equity in earnings ————— — Taxes 1 M-530.61 K00-2.3 M — Non-controlling/minority interest ————— — After tax other income/expense ——-189 K0— — Net income before discontinued operations 14.41 M-11.43 M-27.42 M11.1 M11.9 M 16.45 M Discontinued operations ————— — Net income 14.41 M-11.43 M-27.42 M11.1 M11.9 M 16.45 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 14.47 M-11.43 M-27.42 M-11.12 M-11.85 M -12.93 M Basic earnings per share (Basic EPS) ——-850-212-96.75 -33.5 Diluted earnings per share (Diluted EPS) ——-851.19-212-96.75 -33.5 Average basic shares outstanding ——32.22 K52.46 K122.4 K 3.03 M Diluted shares outstanding ——32.22 K52.46 K122.4 K 3.03 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 1 M790.97 K904.11 K222782 1 204